A grim prognosis, a gamble and one patient’s fight to defy cancer
After a Stage 4 cancer diagnosis and a prognosis of 16 months to live, Katie Doble didn’t know whether she should plan her ...
Le Lézard18h
MySize Inc. Announces Innovative Integrated Virtual Try-On and Sizing Technology Following Successful Participation at CES and NRF 2025
MySize Inc. , a global leader in AI and big data-driven solutions for the retail market, is proud to announce the launch of its Integrated Virtual Try-On Solution, featuring seamless integration with ...
drugtargetreview.com17h
Obstacles and innovations of macrocyclic drug development
Discover the potential of macrocycles in drug discovery: flexible, cell-permeable molecules targeting undruggable proteins.
Le Lézard14h
GenSight Biologics Reports End-of-Year Cash Position and Provides Business Update
GenSight Biologics ("GenSight Biologics" or the "Company") (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene ...